Valuation : Laboratorio Reig Jofre SA

Market Cap 21Cr 0 25Cr 20Cr 18Cr 35Cr 2.38TCr 35Cr 239.85Cr 93Cr 1.21TCr 94Cr 92Cr 3.84TCr P/E 2026 *
13.2x
P/E 2027 * 22x
Enterprise Value 30Cr 0 35Cr 28Cr 26Cr 48Cr 3.31TCr 48Cr 334.37Cr 129.23Cr 1.69TCr 130.75Cr 127.91Cr 5.35TCr EV / Sales 2026 *
0.82x
EV / Sales 2027 * 0.75x
Free-Float
20.57%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 58 01/01/2006
Director of Finance/CFO - 20/12/2023
Chief Tech/Sci/R&D Officer - 01/01/2003
Director TitleAgeSince
Chairman - 31/12/2014
Director/Board Member 58 31/12/2014
Director/Board Member - 07/11/2017
Change 5-day change 1-year change 3-year change Capi.($)
+2.41%-.--% - - 25Cr
+0.03%-3.09%+52.20%+91.69% 1,00200Cr
-0.76%-1.52%+49.94%+66.34% 65TCr
+0.86%-3.49%+19.60%+68.37% 44TCr
-0.80%+0.06%+28.73%+35.45% 35TCr
-0.13%-14.74%+9.13%+26.71% 26TCr
-1.90%-2.61%-2.67%+7.41% 25TCr
-0.48%-10.69%+39.64%+50.82% 21TCr
-1.06%-1.70%-16.73%-57.36% 20TCr
-0.68%-2.85%+25.69%+91.64% 18TCr
Average -0.27%-2.06%+22.84%+42.34% 39.37TCr
Weighted average by Cap. -0.42%-2.39%+32.37%+57.01%

Financials

2026 *2027 *
Net sales 36Cr 0 42Cr 34Cr 31Cr 59Cr 4.04TCr 59Cr 407.21Cr 157.38Cr 2.06TCr 159.23Cr 155.77Cr 6.51TCr 39Cr 0 46Cr 37Cr 34Cr 63Cr 4.33TCr 63Cr 437.34Cr 169.03Cr 2.21TCr 171.02Cr 167.3Cr 6.99TCr
Net income 1.67Cr 0 1.94Cr 1.57Cr 1.43Cr 2.68Cr 184.67Cr 2.69Cr 19Cr 7.2Cr 94Cr 7.29Cr 7.13Cr 298.05Cr 95L 0 1.1Cr 89.45L 81.5L 1.52Cr 105.05Cr 1.53Cr 11Cr 4.1Cr 54Cr 4.15Cr 4.06Cr 169.55Cr
Net Debt 8.47Cr 0 9.84Cr 7.98Cr 7.27Cr 14Cr 936.63Cr 14Cr 95Cr 37Cr 477.17Cr 37Cr 36Cr 1.51TCr 7.87Cr 0 9.15Cr 7.41Cr 6.75Cr 13Cr 870.28Cr 13Cr 88Cr 34Cr 443.37Cr 34Cr 34Cr 1.4TCr
Logo Laboratorio Reig Jofre SA
Laboratorio Reig Jofre SA, formerly Natraceutical SA, is a Spain-based company primarily engaged in the research, development, manufacturing and marketing of drugs. The Company’s activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The Company also provides nutritional cosmetics, and food supplements, among others. It operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.
Employees
-
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!